Effects 4.5 years after an interactive GP educational seminar on antibiotic therapy for respiratory tract infections: a randomized controlled trial

Family Practice
E FerratVincent Renard

Abstract

The few studies assessing long-term effects of educational interventions on antibiotic prescription have produced conflicting results. Our aim was to assess the effects after 4.5 years of an interactive educational seminar designed for GPs and focused on antibiotic therapy in respiratory tract infections (RTIs). The seminar was expected to decrease antibiotic prescriptions for any diagnosis. We conducted a randomized controlled parallel-group trial in a Paris suburb (France), with GPs as the randomization unit and prescriptions as the analysis unit. The intervention occurred in September 2004 and the final assessment in March 2009. Among 203 randomized GPs, 168 completed the study, 70 in the intervention group and 98 in the control group. Intervention GPs were randomized to attending only a 2-day interactive educational seminar on evidence-based guidelines about managing RTIs or also 1 day of problem-solving training. The primary outcome was the percentage of change in the proportion of prescriptions containing an antibiotic for any diagnosis in 2009 versus 2004. An intention-to-treat sensitivity analysis was performed using multiple imputation. After 4.5 years, absolute changes in the primary outcome measure were -1.1% (95% co...Continue Reading

References

Jul 1, 1954·Psychological Bulletin·J C FLANAGAN
Dec 23, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Agence Française de Sécurité Sanitaire des Produits de Santé
Apr 28, 2004·Emerging Infectious Diseases·Werner C AlbrichStephan Harbarth
Jul 30, 2004·The Journal of Antimicrobial Chemotherapy·Samuel CoenenJoke Denekens
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ulla-Maija RautakorpiUNKNOWN MIKSTRA Collaborative Study Group
May 16, 2006·Pharmacoepidemiology and Drug Safety·Monique M ElseviersUNKNOWN ESAC project group
Mar 28, 2007·The Journal of Continuing Education in the Health Professions·Maliheh Mansouri, Jocelyn Lockyer
Nov 4, 2008·Emerging Infectious Diseases·Nienke van de Sande-BruinsmaUNKNOWN European Surveillance of Antimicrobial Consumption Project Group
Jul 1, 2009·BMJ : British Medical Journal·Jonathan A C SterneJames R Carpenter
Jan 13, 2011·Statistics in Medicine·Ian R WhiteAngela M Wood
Dec 6, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Alike W van der VeldenTheo J M Verheij
Jul 10, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Philippe Le CorvoisierClaude Attali

❮ Previous
Next ❯

Citations

Jan 22, 2019·International Journal of Clinical Practice·José M MoleroCarl Llor
Apr 12, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jefferson G BohanUNKNOWN ARI Management Improvement Group
Feb 15, 2020·European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe·Alison BullockDenis Murphy
Feb 26, 2019·Antimicrobial Resistance and Infection Control·Dilip NathwaniClaudie Charbonneau
Jul 2, 2019·The Journal of Antimicrobial Chemotherapy·António Teixeira RodriguesMaria Teresa Herdeiro
Jul 22, 2021·JAC-antimicrobial Resistance·Valerie LeungKevin L Schwartz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.